LUVERIS 75 IU, powder and solvent for solution for injection bottle, 1 ml
Active ingredients: Lutropin alfa
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LUVERIS 75 UI, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon en verre - 1 flacon en verre de 1 mL
- Marketing authorisation holder
- MERCK EUROPE (PAYS-BAS)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Jan 2002
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66457697CIP73549643CIP133400935496430Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LUTROPINE ALFApoudre | 75 UI · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.